Hearing on Preparing for Future Pandemics

C-SPAN is testing some improvements to our website and we’d like to ask for your help.

Please click here to try out our new video viewing page (you can switch back at any time).



Watch LIVE On November 14 | 11:30am ET | C-SPAN3



Federal health officials testify on lessons learned from the COVID-19 pandemic before the House Oversight and Accountability Select Subcommittee on the Coronavirus Pandemic. 

Source link

Visited 1 times, 1 visit(s) today

Related Article

Seemingly “broken” genes in coronaviruses may

image:  Stephen Goldstein, PhD. view more  Credit: Charlie Ehlert / University of Utah Health Viruses are lean, mean, infection machines. Their genomes are tiny, usually limited to a handful of absolutely essential genes, and they shed extra genomic deadweight extremely fast. Usually. Coronaviruses, including SARS-CoV-2 (the virus that causes COVID-19), appear at first glance to

Seemingly ‘broken’ genes in coronaviruses may be essential for viral survival

Coronavirus. Credit: European Centers for Disease Control Viruses are lean, mean, infection machines. Their genomes are tiny, limited to a handful of absolutely essential genes, and they shed extra genomic deadweight extremely fast… usually. Coronaviruses, including SARS-CoV-2 (the virus that causes COVID-19), appear at first glance to be an exception. They have some extra “accessory”

6 in 10 Americans do not plan to get updated COVID vaccine for 2024-25

Pharmacist Deep Patel prepares flu and COVID-19 vaccines for a customer in Huntington Park, California, on Aug. 28, 2024. (Christina House/Los Angeles Times via Getty Images) Six-in-ten Americans say they will probably not get an updated 2024-25 COVID-19 vaccine, according to an October Pew Research Center survey. Smaller shares say they probably will get an

Phase 2 study evaluates safety and efficacy of asunercept in COVID-19 patients

While the trial confirmed asunercept’s safety and tolerability, it failed to achieve statistically significant improvement in clinical outcomes compared to standard care. Study: Efficacy and safety of asunercept, a CD95L-selective inhibitor, in hospitalised patients with moderate-to-severe COVID-19: ASUNCTIS, a multicentre, randomised, open-label, controlled, phase 2 trial. Image Credit: Pormezz/Shutterstock.com In a recent study published in the eClinicalMedicine,

Chairman Wenstrup Delivers Opening Remarks at COVID Select’s Final Hearing

Members and government witnesses set to evaluate lessons learned during the COVID-19 pandemic WASHINGTON — Select Subcommittee on the Coronavirus Pandemic Chairman Brad Wenstrup (R-Ohio) opened today’s hearing titled “Preparing for the Next Pandemic: Lessons Learned and the Path Forward” by detailing the serious flaws in the government’s response to the COVID-19 pandemic. Public health

Woman fired for not taking COVID vax wins verdict

Earlier this month, a federal jury in Michigan handed down a substantial verdict against Blue Cross Blue Shield after it fired a woman who refused to be vaccinated with the COVID-19 vaccine due to religious reasons. Lisa Domski worked for BCBS as an IT Process Specialist when in November 2021 the company announced that it

0
Would love your thoughts, please comment.x
()
x